BCLI Rentabilitas dodolan miturut bathi resik Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. - logo grafis emiten BCLI

Geopolitical instability is complicating reagent logistics and the protection of Brainstorm Cell (BCLI) patents abroad. Operating net profit margins visualize these challenges, with the latest parameter standing at 0.00. There is a serious threat of bankruptcy due to a liquidity shortage and potential regulatory rejections for ALS therapy. However, the market value already prices in R&D risks, awaiting long-term FDA approvals for the drug NurOwn.

BrainStorm Cell Therapeutics Inc. (BCLI) - Rentabilitas dodolan miturut bathi resik saka 04.07.2022 nganti 02.08.2025

Rincian metrik keuangan lan pasar BrainStorm Cell Therapeutics Inc. (BCLI)

Produk asil prodhuksi Brainstorm Cell Therapeutics, Inc.

Net profitability reflects the share of profit remaining after deducting all operating and financial expenses. This metric measures the efficiency of converting revenue into bottom-line income. By analyzing the net profit margin, an investor assesses the business's resilience to rising costs. For Brainstorm Cell (BCLI), the volatility of this metric is driven by R&D expenditures. Geopolitical barriers and the logistics gap in cell therapy are currently exerting critical pressure on the company's final profitability.

Pesaing langsung

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|Margin resik NERV|Margin dodolan resik ATHA|ADXN (Addex Therapeutics Ltd) - Tingkat bathi resik|Margin resik alzamend.com ALZN|Margin dodolan perusahaan Cyclerion Therapeutics (CYCN)|Protagenic - Margin dodolan resik|Tingkat bathi resik KTTA (Pasithea Therapeutics Corp)|CRGT: Margin dodolan resik|Avenue Therapeutics Inc. (ATXI) - Margin dodolan resik|CARA (Cara Therapeutics Inc.) - Margin dodolan resik|Margin resik CHRO|Rentabilitas dodolan miturut bathi resik ELYM (Eliem Therapeutics)|Margin resik ITCI (Intra-Cellular Therapies Inc.)|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel